Skip to main content

Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study

Publication ,  Journal Article
Gu, M; Huang, W; Li, X; Liu, Y; Wang, F; Fang, C; Chen, T
Published in: Nature and Science of Sleep
January 1, 2021

Objective: Hypertriglyceridemic waist (HTGW) phenotype is an independent risk factor for metabolic disorders. Although obstructive sleep apnea (OSA) is associated with metabolic disorders, it is unclear whether there is an association between HTGW phenotype and OSA. Methods: We enrolled consecutive participants presenting to a sleep center in Shanghai, China. Full-night polysomnography was performed, and serum triglyceride (TG) levels and waist circumference (WC) were calculated. HTGW phenotype was defined as increased WC (men > 90 cm, women > 80 cm) and elevated TG levels (> 1.7 mmol/L). Participants were classified into four groups: normal TG with normal WC (NTNW); normal TG with increased WC (NTGW); elevated TG with normal WC (HTNW); and elevated TG with enlarged WC, namely HTGW. The relationships between HTGW phenotypes and OSA were assessed using binary (apnea hypopnea index, [AHI]≥5/hr) and multinomial logistic regression analyses (clinical AHI severity categories). Results: We included 3190 participants in this cross-sectional study. Compared to the NTNW phenotype, participants with NTGW and HTGW phenotypes had the significantly higher risk of OSA (AHI ≥5/hr, odds ratio [OR] = 2.51, 95% confidence interval [CI] = 1.91– 3.31; OR = 3.76, 95% CI = 2.67–5.31, respectively), after adjustment for confounders. In subgroup analyses categorised by age, sex, and BMI, the aforementioned associations remained significant. The association between the NTGW, HTGW phenotype and OSA risk remained significant across the OSA severity groups. Multinomial logistic regression also revealed that the mild (OR = 1.63, 95% CI = 1.07–2.50), moderate (OR = 1.875, 95% CI = 1.22–2.88), and severe OSA (OR = 3.18, 95% CI = 2.14–4.73) were associated with HTGW phenotype. Conclusion: Both NTGW and HTGW phenotype were positively associated with OSA risk in all subgroups. Further longitudinal follow-up studies are needed to determine the causal link and prognostic role of these metabolic factors.

Duke Scholars

Published In

Nature and Science of Sleep

DOI

EISSN

1179-1608

Publication Date

January 1, 2021

Volume

13

Start / End Page

2165 / 2173

Related Subject Headings

  • 5202 Biological psychology
  • 4206 Public health
  • 3209 Neurosciences
  • 1701 Psychology
  • 1109 Neurosciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gu, M., Huang, W., Li, X., Liu, Y., Wang, F., Fang, C., & Chen, T. (2021). Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study. Nature and Science of Sleep, 13, 2165–2173. https://doi.org/10.2147/NSS.S335288
Gu, M., W. Huang, X. Li, Y. Liu, F. Wang, C. Fang, and T. Chen. “Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study.” Nature and Science of Sleep 13 (January 1, 2021): 2165–73. https://doi.org/10.2147/NSS.S335288.
Gu M, Huang W, Li X, Liu Y, Wang F, Fang C, et al. Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study. Nature and Science of Sleep. 2021 Jan 1;13:2165–73.
Gu, M., et al. “Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study.” Nature and Science of Sleep, vol. 13, Jan. 2021, pp. 2165–73. Scopus, doi:10.2147/NSS.S335288.
Gu M, Huang W, Li X, Liu Y, Wang F, Fang C, Chen T. Association of Hypertriglyceridemic Waist Phenotype with Obstructive Sleep Apnea: A Cross-Sectional Study. Nature and Science of Sleep. 2021 Jan 1;13:2165–2173.

Published In

Nature and Science of Sleep

DOI

EISSN

1179-1608

Publication Date

January 1, 2021

Volume

13

Start / End Page

2165 / 2173

Related Subject Headings

  • 5202 Biological psychology
  • 4206 Public health
  • 3209 Neurosciences
  • 1701 Psychology
  • 1109 Neurosciences
  • 1103 Clinical Sciences